Market Cap $314.5M
!
Corporate Spotlight
AFT Pharmaceuticals (ASX:AFP) are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels.
View the full Corporate Spotlight
AFP TARGETING $6 BILLION OPPORTUNITY
Last update - 15.00pm 13/03/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $2.85 | 3000 | 0 | $3.00 | 2677 | |
Directors & Senior Management
| Ms. Allison Yorston | Independent Non-Executive Director |
| Mr. Andrew H. Lane | Independent Non-Executive Director |
| Mr. David Mark Flacks | Independent Chairman |
| Dr. Hartley Atkinson | Co-Founder, CEO, MD & Executive Director |
| Ms. Ioana Stanescu | Chief Scientific Officer |
| Mr. Malcolm Tubby | CFO & Company Secretary |
| Ms. Marree Atkinson | Co-Founder, Chief of Staff & Executive Director |
| Mr. Murray Keith | Group Marketing Manager |
| Dr. Theodore J. Witek | Independent Non-Executive Director |
Data source: ADVFN